These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
5. [Ways of intensification of hemodialysis therapy]. Filiptsev PIa, Kirkhman VV, Timokhov VS. Ter Arkh; 1988 Nov; 60(6):44-7. PubMed ID: 3206368 [Abstract] [Full Text] [Related]
6. Simultaneous hemofiltration/hemodialysis: an effective alternative to hemofiltration and conventional hemodialysis in the treatment of uremic patients. Leber HW, Wizemann V, Goubeaud G, Rawer P, Schütterle G. Clin Nephrol; 1978 Mar; 9(3):115-21. PubMed ID: 639371 [Abstract] [Full Text] [Related]
9. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Nasri H, Baradaran A, Naderi AS. Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479 [Abstract] [Full Text] [Related]
11. [When is hemofiltration indicated, in the treatment of renal insufficiency? (author's transl)]. Pogglitsch H. Acta Med Austriaca; 1980 Aug; 7(4-5):144-7. PubMed ID: 7246019 [Abstract] [Full Text] [Related]
19. Continuous arteriovenous hemodialysis: an alternative therapy for acute renal failure associated with critical illness. Gibney RT, Stollery DE, Lefebvre RE, Sharun CJ, Chan P. CMAJ; 1988 Nov 01; 139(9):861-6. PubMed ID: 3179891 [Abstract] [Full Text] [Related]